United States - English - NLM (National Library of Medicine)

inspira:cosmetics gmbh - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - octinoxate 2 g in 50 ml - ethylhexyl methoxycinnamate cream for uv and ir protection rich day care cream providing uv and ir protection for stressed and dry skin. high-alpine edelweiss combats premature ageing and aggressive environmental influences, while a special active substance with a detoxifying effect purifies the skin and hyaluronic acid and pentavitintm* smoothe it.

United States - English - NLM (National Library of Medicine)

e.l.f. cosmetics, inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 2.0 g in 100 ml - purpose: acne treatment uses: for the treatment of acne helps prevent new acne blemishes

United States - English - NLM (National Library of Medicine)

vvf kansas services llc - aluminum zirconium trichlorohydrex gly (unii: t27d6t99lh) (aluminum zirconium trichlorohydrex gly - unii:t27d6t99lh) - aluminum zirconium trichlorohydrex gly 12.8 g in 64 g - antiperspirant reduces underarm wetness. do not use on broken skin. stop use if rash or irritation occurs.

United States - English - NLM (National Library of Medicine)

exact-rx, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications : sodium sulfacetemide 10% wash is intended for topical application in the following scaling dermatoses: seborrheic dermatisis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. contraindications: sodium sulfacetamide 10% wash is contraindicated in persons with know or suspected hypersensitivity to sulfonamides.

United States - English - NLM (National Library of Medicine)

winning solutions - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - menthol 2.5 g in 106 g - purpose : external analgesic uses: temporarly relieves minor aches and pains of muscles and joints due to - arthritis - simple backache - strains - sprains - bruises

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate 0.5 mg in 1 g - clobetasol propionate cream, usp 0.05% is a super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. use in children under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. clobetasol propionate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations. safety and effectiveness of clobetasol propionate cream in pediatric patients has not been established. use in children under 12 years of age is not recommended. because of a higher ratio of sk

United States - English - NLM (National Library of Medicine)

seton pharmaceuticals - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - lidocaine hydrochloride anhydrous 30 mg in 1 g - product should not be used in patients with a history of sensitivity to any of its ingredients or adverse reactions to lidocaine or amide anesthetics, which usually do not cross-react with “caine” ester type anesthetics. if excessive irritation and significant worsening occur, discontinue use and seek the advice of your physician. product and topical lidocaine should be used cautiously in those with impaired liver function, as well as the very ill or very elderly and those with significant liver disease. product should be used with caution on patients receiving antiarrhythmic drugs of class i since the adverse effects are additive and generally synergistic. these products are contraindicated for tuberculous or fungal lesions or skin vaccinia, varicella and acute herpes simplex. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pregnancy category c. reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine. there are, however, no adequate and well-controlled studies in pregnant women. animal reproduction studies are not always predictive of human response. general consideration should be given to this fact before administering lidocaine to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place. corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. the more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. there are no adequate and well controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time. safety and efficacy in children have not been established.

United States - English - NLM (National Library of Medicine)

vi-jon, llc - benzethonium chloride (unii: ph41d05744) (benzethonium - unii:1vu15b70bp) - benzethonium chloride 1.98 mg in 1 g - antimicrobial - to decrease bacteria on the skin that could cause disease - recommended for repeated use

United States - English - NLM (National Library of Medicine)

cvs pharmacy, inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 19.8 mg in 1 g - acne medication for the treatment of acne

United States - English - NLM (National Library of Medicine)

this works products limited - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - - helps prevent sunburn.